推荐应用
HLA-DRB3 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. The presence of DRB3 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.
推荐稀释比 WB:1/500-1/1000;IHC:1/50-1/100

Western blot analysis of HLADRB3 in Raji lysates using HLADRB3 antibody.

Immunohistochemistry analysis of paraffin-embedded Human tonsil using HLA DRB3 antibody. High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
-25 ~ -15℃保存,收到货之后有效期1年,避免反复冻融。
【应用方向】单细胞表观测序中的抗体应用
23
2026-07-29
【选购指南】类器官研究之构建与起始细胞鉴定抗体推荐
316
2026-07-21
【选购指南】类器官研究之功能成熟度评估抗体推荐
278
2026-07-21
【应用方向】趋化因子信号传导通路——身体“信号导航”解析
289
2026-07-21
【选购指南】重度抑郁症(MDD)通路研究抗体推荐
249
2026-07-21
【选购指南】帕金森病(PD)代谢机制核心抗体研究指南
287
2026-07-21
【应用方向】抗体助力心脏免疫研究——解锁心衰防治新方向
238
2026-07-21
【应用方向】抗体助力心肌肥大与心衰研究:从基础探索到科研应用
279
2026-07-21
【应用方向】抗体助力癌症代谢通路研究——肿瘤代谢科普与研究工具指南
280
2026-07-21
【应用方向】心肌再生研究与抗体应用解决方案——助力心血管修复机制解析
13737
2026-03-18
【应用方向】抗体应用研究——心肌纤维化解析
20384
2026-04-14
【技术讲解】抗体赋能心肌梗死研究—精准靶向,助力科研突破
7339
2026-04-14
【应用方向】抗体应用研究—心肌发育的分子解析与前沿转化
15032
2026-04-14
【应用方向】抗体应用研究—细胞死亡
20268
2026-07-16
【应用方向】经典信号通路-JAK/STAT信号转导通路及抗体推荐
13182
2026-04-14





